Source: Marketing Authorisation Holder Revision Year: 2019
Lectrum 3.75mg.
Lectrum 7.50mg.
Lectrum 11.25mg.
Chemical name: 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-Larginyl-N-ethyl-L-prolinamide
Molecular formula: C59H84N16O12
CAS: 53714-56-0
| Pharmaceutical Form |
|---|
|
Powder for suspension for injection. |
Each vial with powder for suspension for injection contains 3.75mg; 7.5mg or 11.25mg of leuprolide acetate.
| Active Ingredient | Description | |
|---|---|---|
| Leuprorelin |
Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis. |
| List of Excipients |
|---|
Excipients Lectrum 3.75 mg and Lectrum 7.5 mgGelatine Each vial of diluent contains: Sodium carboxymethylcellulose Excipients Lectrum 11.25 mgGelatine Each vial of diluent contains: Sodium carboxymethylcellulose |
| Drug | Countries | |
|---|---|---|
| LECTRUM | Brazil, Ecuador |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
